Kuehs U - Search Results

1

Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer.

Merseburger AS, Hennenlotter J, Simon P, Kruck S, Koch E, Horstmann M, Kuehs U, Küfer R, Stenzl A, Kuczyk MA. Merseburger AS, et al. Among authors: kuehs u. Anticancer Res. 2005 May-Jun;25(3B):1901-7. Anticancer Res. 2005. PMID: 16158924 Free article.

2

Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?

Horstmann M, Geiger LM, Vogel U, Schmid H, Hennenlotter J, Kuehs U, Merseburger AS, Kruck S, Stenzl A, Bedke J. Horstmann M, et al. Among authors: kuehs u. World J Urol. 2012 Aug;30(4):525-31. doi: 10.1007/s00345-011-0763-3. Epub 2011 Sep 18. World J Urol. 2012. PMID: 21928123

3

Cathepsin D expression in renal cell cancer-clinical implications.

Merseburger AS, Hennenlotter J, Simon P, Ohneseit PA, Kuehs U, Kruck S, Koch E, Vogel U, Stenzl A, Kuczyk MA. Merseburger AS, et al. Among authors: kuehs u. Eur Urol. 2005 Sep;48(3):519-26. doi: 10.1016/j.eururo.2005.03.019. Epub 2005 Apr 7. Eur Urol. 2005. PMID: 16115525

4

PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activation.

Hennenlotter J, Ohneseit PA, Simon P, Merseburger AS, Serth J, Kuehs U, Kramer M, Hartmann JT, Stenzl A, Kuczyk MA. Hennenlotter J, et al. Among authors: kuehs u. Oncol Rep. 2008 May;19(5):1141-7. Oncol Rep. 2008. PMID: 18425369

5

Activation of PI3K is associated with reduced survival in renal cell carcinoma.

Merseburger AS, Hennenlotter J, Kuehs U, Simon P, Kruck S, Koch E, Stenzl A, Kuczyk MA. Merseburger AS, et al. Among authors: kuehs u. Urol Int. 2008;80(4):372-7. doi: 10.1159/000132694. Epub 2008 Jun 27. Urol Int. 2008. PMID: 18587247

6

Activation of mTOR in renal cell carcinoma is due to increased phosphorylation rather than protein overexpression.

Kruck S, Bedke J, Hennenlotter J, Ohneseit PA, Kuehs U, Senger E, Sievert KD, Stenzl A. Kruck S, et al. Among authors: kuehs u. Oncol Rep. 2010 Jan;23(1):159-63. Oncol Rep. 2010. PMID: 19956876

7

Evaluation of the KIT/stem cell factor axis in renal tumours.

Horstmann M, Hennenlotter J, Geiger LM, Vogel U, Schmid H, Kuehs U, Stenzl A, Bedke J. Horstmann M, et al. Among authors: kuehs u. Anticancer Res. 2012 Oct;32(10):4339-45. Anticancer Res. 2012. PMID: 23060556

8

Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma.

Amend B, Hennenlotter J, Scharpf M, Kruck S, Kuehs U, Senger E, Merseburger AS, Kuczyk MA, Sievert KD, Stenzl A, Bedke J. Amend B, et al. Among authors: kuehs u. World J Urol. 2012 Jun;30(3):353-9. doi: 10.1007/s00345-011-0737-5. Epub 2011 Aug 7. World J Urol. 2012. PMID: 21822918

9

XPA-210: a new proliferation marker to characterize tumor biology and progression of renal cell carcinoma.

Gakis G, Hennenlotter J, Scharpf M, Hevler J, Schilling D, Kuehs U, Stenzl A, Schwentner C. Gakis G, et al. Among authors: kuehs u. World J Urol. 2011 Dec;29(6):801-6. doi: 10.1007/s00345-010-0621-8. Epub 2010 Nov 27. World J Urol. 2011. PMID: 21113600

10

Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.

Kruck S, Hennenlotter J, Vogel U, Schilling D, Gakis G, Hevler J, Kuehs U, Stenzl A, Schwentner C. Kruck S, et al. Among authors: kuehs u. BJU Int. 2012 Feb;109(4):634-8. doi: 10.1111/j.1464-410X.2011.10392.x. Epub 2011 Jun 28. BJU Int. 2012. PMID: 21711439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters